Weekly new calls from the National Institutes of Health (NIH) November 2, 2012

The National Institutes of Health's (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability. It is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions around the world.

These are the weekly NIH funding opportunities of November 2, 2012:
• Alzheimer's Disease Therapeutics Program (U01): Letter of Intent Due Date December 14, 2012;
• Epigenomics of Virus-Associated Oral Diseases (R01): Letter of Intent Due Date(s) January 21, 2013;
• Epigenomics of Virus-Associated Oral Diseases (R21): Letter of Intent Due Date(s) January 21, 2013;
• Prescription Drug Abuse (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Prescription Drug Misuse (R21): Application Receipt Date(s): Multiple receipt dates, see announcement;
• Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3): Letter of Intent Due Date(s) March 2, 2013.

For more active Requests for Applications (RFAs) and Program Announcements (PAs) please click here.